dehydroepiandrosterone sulfate has been researched along with Pulmonary Hypertension in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chalupský, K; D Uris Ova, J; Hampl, V; Kaftanová, B; Krása, K; Miková, D; Minaříkova, M; Srbová, M; Vajnerova, O | 1 |
Archer-Chicko, C; Baird, GL; Barr, RG; Bluemke, DA; Foderaro, AE; Fritz, JS; Hill, NS; Kawut, SM; Klinger, JR; Lima, JAC; Mullin, CJ; Ouyang, P; Palevsky, HI; Palmisicano, AJ; Pinder, D; Preston, IR; Roberts, KE; Smith, KA; Ventetuolo, CE; Walsh, T; Whittenhall, M | 1 |
Baird, GL; Barr, RG; Bluemke, DA; Fritz, JS; Hill, NS; Kawut, SM; Klinger, JR; Krishnan, I; Lima, JA; Ouyang, P; Palevsky, HI; Palmisciano, AJ; Pinder, D; Preston, IR; Roberts, KE; Ventetuolo, CE | 1 |
Bíbová, J; Hampl, V; Herget, J; Povýsilová, V | 1 |
Fagan, KA; Gebb, SA; Golembeski, SM; Homma, N; Imamura, M; Karoor, V; Limbird, J; McMurtry, IF; Nagaoka, T; Oka, M; Sakao, E | 1 |
Dubuis, E | 1 |
6 other study(ies) available for dehydroepiandrosterone sulfate and Pulmonary Hypertension
Article | Year |
---|---|
Simvastatin and dehydroepiandrosterone sulfate effects against hypoxic pulmonary hypertension are not additive.
Topics: Animals; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Hypertension, Pulmonary; Hypoxia; Male; Pulmonary Artery; Rats; Simvastatin | 2022 |
Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.
Topics: Aged; Body Mass Index; Case-Control Studies; Connective Tissue Diseases; Dehydroepiandrosterone Sulfate; Estradiol; Female; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Male; Middle Aged; Postmenopause; Proportional Hazards Models; Risk Factors; Walk Test | 2018 |
Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men.
Topics: Aged; Case-Control Studies; Dehydroepiandrosterone Sulfate; Estradiol; Humans; Hypertension, Pulmonary; Male; Middle Aged; Risk Factors | 2016 |
Dehydroepiandrosterone sulphate reduces chronic hypoxic pulmonary hypertension in rats.
Topics: Adjuvants, Immunologic; Animals; Chronic Disease; Dehydroepiandrosterone Sulfate; Hypertension, Pulmonary; Hypoxia; Male; Models, Animal; Potassium Channels, Calcium-Activated; Rats; Rats, Wistar | 2003 |
Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
Topics: Acetylcholine; Animals; Blotting, Western; Cyclic GMP; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Guanylate Cyclase; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroprusside; Pulmonary Artery; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Testosterone; Up-Regulation; Vasodilator Agents | 2007 |
DHEA treatment of pulmonary hypertension: new insights into a complex mechanism.
Topics: Animals; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Guanylate Cyclase; Humans; Hypertension, Pulmonary; Models, Animal; Muscle, Smooth, Vascular; Nitric Oxide; Pulmonary Artery; Rats; Testosterone | 2007 |